Risk Factors for Early Cytomegalovirus Reactivation and Impact of Early Cytomegalovirus Reactivation on Clinical Outcomes after T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide

This publication has 41 references indexed in Scilit:

• Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients
  Blood, 2011
• Nonmyeloablative HLA-Haploidentical Bone Marrow Transplantation with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on Outcome
  Transplantation and Cellular Therapy, 2010
• Defining the Intensity of Conditioning Regimens: Working Definitions
  Transplantation and Cellular Therapy, 2009
• HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
  Transplantation and Cellular Therapy, 2008
• Epidemiologic Analysis of Reactivated Cytomegalovirus Antigenemia in Patients with Cancer
  Journal of Clinical Microbiology, 2007
• National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report
  Transplantation and Cellular Therapy, 2005
• Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
  Blood, 2005
• The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy
  Blood, 2004
• Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide
  Transplantation and Cellular Therapy, 2002
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958